Groundbreaking pan-European study by Alpharmaxim and Aston University harnesses behavioural science to uncover factors influencing prescribing practice in Parkinson's Disease and identifies clear opportunities to improve treatment options

Alpharmaxim England United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/groundbreaking-pan-european-study-by-alpharmaxim-and-aston-university-harnesses-behavioural-science-to-uncover-factors-influencing-prescribing-practice-in-parkinsons-disease-and-identifies-clear-opportunities-to-improve-treatment-302496785.html